Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, along with members of Pliant’s senior management team, will participate in virtual fireside chats at the following investor conferences:
Piper Sandler 33rd Annual Virtual Healthcare Conference – Pliant’s pre-recorded fireside chat will be available on Monday, November 22, 2021, at 10:00am ET
Evercore ISI 4th Annual HealthconX Conference – Pliant will participate in a fireside chat on Tuesday, November 30, 2021, at 3:30pm ET
Interested parties can access these presentations from the Investor Relations’ Events & Presentation page of Pliant’s website at https://ir.pliantrx.com/news-and-events/events-and-presentations with an audio archive of these fireside chats available for 90 days from the time they are made available.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.